Evidence map›Paper›PMID 18708617›Full record

ArticleInvestigative ophthalmology & visual science2008

Drug delivery to posterior intraocular tissues: third Annual ARVO/Pfizer Ophthalmics Research Institute Conference.

Henry F Edelhauser, Jeffrey H Boatright, John M Nickerson, Third ARVO/Pfizer Research Institute Working Group

Abstract readConference Proceedings
PubMed Full text at PMC Publisher
In one paragraph

Article in Investigative ophthalmology & visual science, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Drug and gene delivery to the back of the eye: from bench to bedside.Investigative ophthalmology & visual science · 2014
    Review
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Henry F EdelhauserDepartment of Ophthalmology, Emory University, Atlanta, Georgia 30322, USA. ophthfe@emory.edu
Jeffrey H Boatright
John M Nickerson
Third ARVO/Pfizer Research Institute Working Group

Funding

P30-Core Grant for Vision Research Core CP30EY006360 · NEI · EMORY UNIVERSITY · PI BOATRIGHT, JEFFREY H · 1986 to 2025
$15.3M
Transscleral Drug Delivery for Retinal DisordersR24EY017045 · NEI · EMORY UNIVERSITY · PI EDELHAUSER, HENRY FRANCIS · 2006 to 2010
$6.9M
VIsion Science Training in AtlantaT32EY007092 · NEI · EMORY UNIVERSITY · PI Machelle T. Pardue · 1985 to 2026
$4.6M
Oligonucleotide Repair of a Retinal Degeneration ModelR01EY014026 · NEI · EMORY UNIVERSITY · PI BOATRIGHT, JEFFREY H · 2004 to 2015
$4.1M
Gene Delivery in Retinal DiseasesR01EY016470 · NEI · EMORY UNIVERSITY · PI NICKERSON, JOHN M · 2006 to 2015
$3.2M
PATHOGENESIS OF CORNEAL EDEMA AFTER INTRAOCULAR SURGERYR01EY000933 · NEI · MEDICAL COLLEGE OF WISCONSIN · PI EDELHAUSER, HENRY FRANCIS · 1985 to 2006
$2.1M
NEI NIH HHS P30 EY006360NEI NIH HHS R01 EY000933NEI NIH HHS R01 EY014026NEI NIH HHS R01 EY016470NEI NIH HHS R24 EY017045NEI NIH HHS R24-EY017045NEI NIH HHS T32 EY007092
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Drug Delivery SystemsAnimalsBiomedical ResearchChoroidChoroid DiseasesEquipment DesignHumansOphthalmic SolutionsRetinaRetinal DiseasesOphthalmic Solutions

Identifiers

PMID18708617
PMCPMC2633627

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.